Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG vs QLB for Total Hip Arthroplasty
NCT05654519Completed
- Sponsor
- Necmettin Erbakan University
- Start
- Jan 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Necmettin Erbakan University. Primary endpoints: Pain scores at 24 hours and Opioid consumption at 24 hours. Started Jan 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05654519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05654519.